These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 5493731

  • 1. Haemophilia.
    Dormandy KM, Currey HL.
    Rep Rheum Dis; 1970 Oct; 42():1-2. PubMed ID: 5493731
    [No Abstract] [Full Text] [Related]

  • 2. Management of musculo-skeletal complications of hemophilia.
    Srivastava RK, Sinha RS, Mehrotra V.
    Indian Pediatr; 1984 Dec; 21(12):965-70. PubMed ID: 6442986
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of haemophilia.
    Ludlam CA.
    Br J Haematol; 1998 May; 101 Suppl 1():13-4. PubMed ID: 9607736
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G.
    Hamatol Bluttransfus; 1968 May; 5():29-42. PubMed ID: 5729465
    [No Abstract] [Full Text] [Related]

  • 9. [Experience from the Hemophilia Clinic. 3. Intramuscular hemorrhages in hemophilia].
    van Creveld S, Mochtar IA, van Donk H.
    Ned Tijdschr Geneeskd; 1970 Apr 25; 114(17):719-22. PubMed ID: 5444639
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of hemophilia].
    Stavem P, Hjort PF.
    Tidsskr Nor Laegeforen; 1970 Jul 01; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V, Parquet A, Tahiri C, Claeyssens S, Potard V, Faradji A, Peynet J, Costagliola D, Suivi Thérapeutique National des Hémophiles Group.
    Br J Haematol; 2002 Feb 01; 116(2):383-9. PubMed ID: 11841442
    [Abstract] [Full Text] [Related]

  • 13. [Technic of obtaining the antihemophilic factors VIII and IX and their clinical application].
    Triginer J, Vila M, Vicente Arangüena P.
    Sangre (Barc); 1979 Feb 01; 24(5-C):937-41. PubMed ID: 121169
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG, Renger FG.
    Z Arztl Fortbild (Jena); 1983 Feb 01; 77(19):807-10. PubMed ID: 6417919
    [No Abstract] [Full Text] [Related]

  • 16. Treatment and prophylaxis of arthropathy in severe hemophilia.
    Ahlberg A.
    Clin Orthop Relat Res; 1967 Feb 01; 53():135-46. PubMed ID: 5586853
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.